Ridaura Capsule
Product Images NDC 54766-093

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ridaura (NDC 54766-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca09306001 Ridaura 3mg

Ca09306001 Ridaura 3mg
This is a description of a pharmaceutical product named "Ridaura", which comes in the form of capsules containing Auranofin. The product is meant to be taken orally and is available in two different doses i.e., 3 mg twice a day or 6 mg once a day as prescribed by the physician. Safety closures must be used when dispensing this product. The product comes in a blue color container and must be stored at a temperature between 15°C and 30°C. For further information, the user should read the accompanying prescribing information or contact the manufacturer.*
FDA Label Image

Lb09306001

Lb09306001
This is a medication called auranofin, with a usual adult dosage of 3 mg twice daily or 6 mg once daily, and it is stored between 15°-30°C (59°-86°F). The medication comes in capsules and should be dispensed in a tight, light-resistant container with safety closures. It is distributed by Sebela Pharmaceuticals Inc. For more information, see the accompanying prescribing information.*
FDA Label Image

Chemical Structure (Rid01 0003 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.